NuVasive earns expanded FDA clearance for TLX interbody system: 6 highlights

Spinal Tech

NuVasive received an expanded clearance for its TLX interbody system for spinal fusion.

Here are six highlights:


1. The clearance included an expandable 20 degree cage as well as more indications for use, such as with allogeneic bone graft and in more spine levels.


2. Surgeons may now use the system in the thoracic spine and at the thoracolumbar junction to treat disc degeneration disease or degenerative spondylolisthesis at one or two adjacent levels.


3. Intended for use during transforaminal lumbar interbody fusion, the TLX system features a low-profile, bulleted design.


4. The system restores sagittal alignment with personalized lordosis degrees.


5. Before this clearance, surgeons could choose among the system's 15 degree lordotic options. Additionally, the TLX system was only indicated for use with allograft.


6. Surgeons may leverage the TLX interbody system with NuVasive’s Global Alignment software, which helps calculate, correct and confirm pathology.



Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers